Rifampin
Rifampin
10 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Rifampin
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Epic Pharma LLC | generic | 6 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 5 | SUPPLYING |
| ANI Pharmaceuticals, Inc. | generic | 5 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | generic | 3 | SUPPLYING |
| A-S Medication Solutions | repackager | 2 | SUPPLYING |
| Chartwell RX, LLC | generic | 2 | SUPPLYING |
| PuraCap Laboratories LLC dba Blu Pharmaceuticals | unknown | 2 | SUPPLYING |
| American Health Packaging | repackager | 2 | SUPPLYING |
| Coupler LLC | repackager | 1 | SUPPLYING |
| Major Pharmaceuticals | relabeler | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Failed Impurities/Degradation Specification. — Recalling firm: Amerisource Health Services LLC — Nationwide in the USA
Subpotent Drug and Failed Impurities/Degradation Specifications — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to 32 Wholesale/distributor accounts who further distributed the product to 156 distribution si…
Subpotent Drug and Failed Impurities/Degradation Specifications — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to 32 Wholesale/distributor accounts who further distributed the product to 156 distribution si…
Failed Impurities/Degradations Specifications — Recalling firm: Amerisource Health Services LLC — Nationwide in the USA.
Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study. — Recalling firm: Lupin Pharmaceuticals Inc. — Distributed Nationwide in the USA
CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed nationwide.
Rifampin Capsule — reported in shortage by Epic Pharma, LLC. Therapeutic category: Anti-Infective.
Rifampin Capsule — reported in shortage by Lupin Pharmaceuticals, Inc.. Therapeutic category: Anti-Infective.